ArticleKidney international2020
Vasopressin V2 receptor antagonists in autosomal dominant polycystic kidney disease: efficacy, safety, and tolerability.
Esther Meijer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it